rna
interfer
rnai
mechan
inhibit
express
specif
gene
doublestrand
rna
dsrna
transfect
small
interf
rna
sirna
molecul
mammalian
cell
result
degrad
target
gene
mrna
silenc
express
applic
rnai
signific
impact
probe
gene
function
promis
provid
new
strategi
develop
novel
therapeut
antivir
versatil
rnai
make
technolog
particularli
attract
pursuit
antivir
therapi
direct
viral
diseas
includ
mani
viral
diseas
livestock
success
appli
inhibit
replic
human
anim
virus
includ
hepat
c
viru
hepat
b
viru
polioviru
footandmouth
diseas
viru
transmiss
gastroenter
viru
tgev
bovin
viral
diarrhea
viru
porcin
reproduct
respiratori
syndrom
viru
classic
swine
fever
viru
vitro
vivo
porcin
hemagglutin
encephalomyel
viru
phecov
first
isol
canada
suckl
piglet
encephalomyel
isol
swine
worldwid
subclin
infect
among
swine
frequent
phecov
caus
encephalomyel
vomit
wast
diseas
suckl
piglet
piglet
younger
week
infect
phecov
mortal
rate
rang
pig
older
week
show
obviou
clinic
sign
phecov
member
antigen
group
ii
coronavirus
along
bovin
coronaviru
bcv
human
coronaviru
hcv
strain
turkey
coronaviru
tcv
mous
hepat
viru
mhv
member
group
possess
five
structur
protein
nucleocapsid
n
membran
small
membran
sm
spike
hemagglutininesteras
associ
granular
project
locat
near
base
typic
larg
bulbou
peplom
display
hemagglutin
ha
activ
open
read
frame
orf
potenti
encod
nonstructur
ns
protein
includ
replicas
polyprotein
r
identifi
number
size
r
gene
differ
coronaviru
speci
import
rna
replic
transcript
possess
antigen
determin
trigger
immun
respons
product
antibodi
neutral
viru
infect
inhibit
ha
activ
larg
multifunct
protein
form
larg
petalshap
spike
surfac
virion
play
central
role
biolog
pathogenesi
coronavirus
avail
complet
genom
sequenc
phecov
genbank
access
enabl
design
sirna
aim
phecov
design
specif
sirna
target
r
gene
order
test
whether
rnai
could
select
target
phecov
viral
rna
studi
provid
experiment
basi
develop
new
antiphecov
strategi
also
new
approach
studi
phecov
infect
replic
prior
infect
strain
phecov
pig
kidney
cell
line
maintain
mem
supplement
fetal
bovin
serum
antibiot
streptomycin
uml
penicillin
incub
overnight
virusinfect
cell
show
cytopath
effect
cpe
cultur
collect
subject
three
freezethaw
cycl
serial
dilut
ad
cell
plate
day
infect
viral
tissu
cultur
infecti
dose
calcul
use
reed
muench
method
assay
perform
triplic
plate
eight
replic
per
dilut
posit
antiphecov
serum
neg
control
serum
prepar
describ
previous
base
recent
research
success
experi
ambion
corpor
research
use
genbank
sequenc
genbank
access
conserv
area
select
ambion
sirna
target
design
onlin
tool
util
choos
four
sequenc
target
r
mrna
blastn
search
conduct
sequenc
ensur
gene
specif
two
sequenc
chosen
sirna
r
two
sequenc
chosen
revers
sequenc
use
neg
sirna
control
scrambl
sirna
five
sirna
molecul
synthes
silencertm
sirna
construct
kit
ambion
accord
manufactur
protocol
sequenc
oligo
dna
synthes
shanghai
sangon
biolog
engin
technolog
servic
co
ltd
sequenc
shown
tabl
cell
seed
plate
cellswel
incub
h
atmospher
cell
confluent
sirna
introduc
use
lipofectamin
transfect
reagent
invitrogen
carlsbad
calif
usa
accord
manufactur
protocol
briefli
transfect
reagent
sirna
ad
well
incub
h
cell
wash
mem
cultur
h
mem
supplement
fetal
bovin
serum
prior
viral
infect
sirnatr
cell
infect
phecov
infect
allow
proceed
indic
time
point
cpe
evalu
invert
fluorescencephasecontrast
microscopi
nikon
differ
time
point
postinfect
infect
cell
visual
indirect
immunofluoresc
assay
ifa
h
postinfect
cultur
supernat
phecovinfect
cell
collect
infecti
viru
product
determin
hemagglutin
ha
test
assay
copi
number
phecov
genom
rna
determin
realtim
rtpcr
ha
titer
infecti
viru
product
plate
determin
ha
test
describ
previous
chicken
red
blood
cell
dilut
physiolog
salin
ad
volum
ml
equal
volum
antigen
dilut
plastic
agglutin
tray
sampl
test
duplic
result
read
settl
pattern
method
h
room
temperatur
presenc
ha
read
posit
test
result
phecov
wherea
absenc
ha
read
neg
test
result
studi
inhibitori
effect
rnai
phecov
replic
level
viral
antigen
produc
cell
examin
ifa
use
antiphecov
serum
sirna
transfect
viral
infect
h
postphecov
infect
infect
cell
visual
indirect
ifa
describ
previous
cell
wash
time
pb
incub
fitcconjug
rabbit
antipig
igg
sigma
h
wash
cell
photograph
examin
zeiss
axioskop
fluoresc
microscop
use
genbank
sequenc
genbank
access
conserv
area
select
primer
design
phecov
use
primer
express
softwar
three
primer
synthes
jikang
shanghai
china
quantif
phecov
genom
realtim
pcr
nfp
primer
nrp
primer
taqman
probe
target
region
realtim
rtpcr
nucleotid
n
protein
gene
phecov
phecovinfect
cell
well
cultur
supernat
collect
h
viral
infect
total
rna
ng
extract
purifi
use
trizol
ls
reagent
invitrogen
pcr
use
amplifi
n
gene
nfp
nrp
primer
condit
min
cycl
final
extens
min
pcr
product
gelpurifi
use
agaros
gel
dna
extract
kit
roch
clone
vector
promega
corp
madison
wisc
usa
result
plasmid
ptn
correct
sequenc
confirm
direct
sequenc
select
quantit
standard
determin
viral
rna
copi
number
realtim
pcr
perform
abi
sequenc
detect
system
use
prob
pcr
kit
qiagen
hilden
germani
condit
min
follow
cycl
denatur
anneal
extens
quantit
standard
curv
determin
phecov
genom
copi
number
creat
realtim
pcr
standard
plasmid
ptn
prepar
serial
dilut
specif
realtim
pcr
confirm
sequenc
product
vitro
transcript
sirna
see
figur
studi
phecovinduc
cpe
fig
cell
infect
phecov
plate
h
infect
cell
examin
phasecontrast
microscopi
everi
h
virusinfect
cell
exhibit
obviou
morpholog
chang
start
brim
well
h
postinfect
h
viral
infect
whole
cell
began
fall
piec
lost
adhes
plate
cell
transfect
four
separ
sirna
prior
infect
phecov
h
viral
infect
imag
cell
captur
analysi
cell
morpholog
indic
neg
control
scrambl
sirna
inhibitori
effect
phecovinduc
cpe
compar
mock
control
noninfect
cell
stuck
tightli
plate
remain
good
condit
throughout
experi
contrast
four
speci
sirna
effect
block
cpe
cell
cultur
h
data
shown
fig
studi
inhibitori
effect
rnai
phecov
replic
level
viral
antigen
produc
cell
examin
ifa
use
antiphecov
serum
sirna
transfect
viral
infect
h
postphecov
infect
cell
mocktransfect
receiv
scrambl
sirna
exhibit
bright
green
fluoresc
cytoplasm
indic
cell
virusproduc
fig
b
contrast
cell
well
receiv
transfect
display
green
fluoresc
indic
cell
effect
protect
sirna
resist
viral
infect
fig
cultur
supernat
phecovinfect
cell
collect
ha
titer
determin
examin
effect
sirna
product
viabl
viru
plate
result
fig
show
control
cell
transfect
scrambl
sirna
phecov
ha
titer
reach
h
postinfect
similar
observ
mocktransfect
cell
contrast
titer
h
postinfect
cell
transfect
respect
correspond
reduct
comparison
scrambl
sirnatransfect
cell
assay
perform
examin
effect
sirna
product
viabl
viru
result
fig
show
control
cell
transfect
scrambl
sirna
phecov
titer
reach
h
postinfect
similar
obtain
mock
transfect
contrast
titer
h
postinfect
cell
transfect
respect
correspond
reduct
comparison
scrambl
sirnatransfect
cell
quantifi
effect
sirna
viral
replic
h
postvir
infect
viral
genom
copi
number
determin
realtim
pcr
use
serial
dilut
plasmid
ptn
standard
valu
standard
curv
averag
amplif
effici
e
sequenc
show
fragment
amplifi
expect
part
phecov
gene
therebi
demonstr
specif
reliabl
analysi
shown
figur
copi
number
viral
genom
per
nanogram
total
rna
calcul
standard
curv
copiesng
viral
genom
total
rna
scrambl
sirnatr
cell
wherea
copiesng
viral
genom
total
rna
cell
treat
respect
valu
correspond
reduct
respect
porcin
hemagglutin
encephalomyel
phe
infecti
diseas
mainli
affect
pig
younger
week
even
infect
pig
surviv
diseaseassoci
immunopatholog
toxic
drug
treatment
phe
acut
affect
growth
increas
research
attent
focus
phe
infect
rate
increas
countri
phe
caus
phecov
viru
one
known
strain
known
cov
neurotrop
pig
viru
spread
via
peripher
nerv
cn
main
propag
site
nerv
cell
primari
target
viral
replic
regener
capac
nerv
cell
weak
cell
damag
patholog
remain
even
viru
elimin
studi
phecov
replic
control
inhibit
infect
great
signific
current
effect
prevent
measur
cure
diseas
exist
recent
replic
variou
virus
includ
mani
coronavirus
shown
effect
inhibit
vitro
vivo
knockdown
bp
sequencehomologydriven
sirna
sirna
therapi
inhibit
differ
level
viral
function
includ
transcript
translat
effect
rapid
silenc
target
gene
achiev
use
vitro
transcrib
sirna
transfect
mammalian
cell
present
studi
design
four
sirna
molecul
phecov
r
gene
prepar
sirna
vitro
transcript
test
effici
rnai
viral
replic
assess
cpe
ifa
ha
rt
qpcr
result
demonstr
four
sirna
highli
capabl
inhibit
viral
rna
genom
replic
phecov
member
coronavirida
famili
whose
gene
express
involv
seri
complex
transcript
translat
posttransl
regulatori
mechan
receptormedi
entri
replicas
polyprotein
encod
orf
compris
approxim
twothird
genom
begin
end
first
viral
protein
translat
translat
replicas
polyprotein
involv
ribosom
frameshift
frame
immedi
upstream
orf
translat
termin
codon
genbank
access
mani
studi
shown
sirna
target
r
gene
effici
inhibit
viral
replic
addit
similar
coronavirus
spike
protein
phecov
spike
glycoprotein
contain
two
noncoval
associ
function
subunit
genbank
access
thought
bind
subunit
cellular
receptor
induc
conform
chang
lead
fusion
viral
cellular
membran
thu
viral
entri
variat
protein
strain
coronavirus
respons
differ
host
rang
tissu
tropism
base
knowledg
chose
r
gene
rnai
target
result
demonstr
two
key
gene
import
phecov
replic
studi
knowledg
kinet
phecov
replic
cultur
cell
critic
determin
sampl
point
estim
sirna
effect
cell
henc
replic
kinet
phecov
cell
studi
cpe
ha
assay
prior
sirna
transfect
viral
prolifer
shown
peak
h
postinfect
data
shown
base
inform
cell
cultur
ifa
viral
titrat
rna
extract
harvest
h
postinfect
result
cpe
analysi
show
virusproduc
cpe
observ
h
postinfect
cell
treat
examin
level
viral
inhibit
test
viral
titer
infect
cell
show
sirna
caus
approxim
decreas
viru
yield
addit
analysi
confirm
effici
inhibit
viral
replic
studi
due
viral
rna
degrad
design
pair
primer
specif
n
gene
phecov
show
realtim
pcr
approxim
less
viral
rna
exist
cell
transfect
sirna
compar
control
cell
verifi
suppress
infect
occur
rna
level
fact
pair
primer
design
amplifi
region
within
n
gene
could
amplifi
region
within
phecov
rna
genom
subgenom
mrna
except
shortest
one
simultan
reduct
viral
rna
suggest
viral
genom
rna
also
transcript
requir
viral
structur
protein
express
decreas
virus
prone
error
replic
continu
produc
mutat
viral
protein
escap
attack
sirna
vitro
transcrib
sirna
effect
reduc
viral
replic
howev
subunit
spike
glycoprotein
essenti
structur
protein
prone
high
mutat
rate
viru
evolv
host
popul
ensur
could
use
wide
rang
viru
strain
evalu
crossinhibitori
capabl
sirna
conduct
multipl
align
gene
sequenc
phecov
strain
base
avail
genbank
result
show
could
cover
phecov
strain
respect
data
shown
indic
addit
studi
conduct
search
sirna
widest
crossinhibitori
effect
rang
phecov
strain
success
use
sirna
therapeut
protect
agent
wild
limit
particularli
natur
infect
sequenc
data
avail
success
isol
viru
circumv
problem
replicas
gene
phecov
highli
conserv
among
differ
strain
target
result
demonstr
sirna
could
block
viral
replic
high
effici
studi
perform
util
infect
strain
whose
sequenc
avail
genbank
howev
studi
impli
sequenc
ident
strain
rnai
highli
sequencespecif
requir
ident
clearanc
viru
cell
cultur
target
target
sequenc
applic
one
sirna
ident
sequenc
infect
viru
one
sirna
sequenc
target
differ
conserv
region
gene
way
overcom
lack
knowledg
target
sequenc
howev
addit
studi
perform
confirm
hypothesi
vitro
vivo
conclus
result
indic
phecov
like
ssrna
virus
suscept
degrad
via
rnai
pathway
method
may
complet
inhibit
viral
growth
merit
anim
studi
defin
therapeut
potenti
addit
sirna
could
potenti
deliv
anim
via
transgen
erad
anim
viral
infect
base
present
data
advantag
sirna
technolog
propos
combin
sirna
target
r
gene
may
use
tool
studi
phecov
replic
antivir
therapi
transgen
anim
futur
studi
